# Effect of Treatment of Sleep Apnea in Patients With Paroxysmal Atrial Fibrillation

Study · id `cardio:ct-nct02727192` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02727192](<https://clinicaltrials.gov/study/NCT02727192>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02727192

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 109 participants.

## Technical summary

Registry record NCT02727192. Randomized; no masking; primary purpose treatment. Start 2016-01-21 (actual); primary completion 2019-07-01 (actual). Results posted on 2021-06-22.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 109 participants (enrolled count; ClinicalTrials.gov record NCT02727192, source copy `cardio:ctgov-nct02727192-2021-06-22`, retrieved 2026-10-26)
- Started: 2016-01-21 (actual) (ClinicalTrials.gov record NCT02727192, source copy `cardio:ctgov-nct02727192-2021-06-22`, retrieved 2026-10-26)
- Primary completion: 2019-07-01 (actual) (ClinicalTrials.gov record NCT02727192, source copy `cardio:ctgov-nct02727192-2021-06-22`, retrieved 2026-10-26)
- Completion: 2020-09 (actual) (ClinicalTrials.gov record NCT02727192, source copy `cardio:ctgov-nct02727192-2021-06-22`, retrieved 2026-10-26)
- Results first posted: 2021-06-22 (ClinicalTrials.gov record NCT02727192, source copy `cardio:ctgov-nct02727192-2021-06-22`, retrieved 2026-10-26)
- Countries: Norway (ClinicalTrials.gov record NCT02727192, source copy `cardio:ctgov-nct02727192-2021-06-22`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02727192-2021-06-22`, retrieved 2026-10-26)

## The registry's words

- Brief title: Effect of Treatment of Sleep Apnea in Patients With Paroxysmal Atrial Fibrillation
- Condition: Sleep Disordered Breathing
- Condition: Sleep Apnea
- Condition: Paroxysmal Atrial Fibrillation
- Intervention (Device): PAP (CPAP or ASV)
- Lead sponsor: Oslo University Hospital
- Lead sponsor class: OTHER
- Collaborator: Norwegian Health Association
- Collaborator class: OTHER
- Collaborator: Medtronic
- Collaborator class: INDUSTRY
- Collaborator: ResMed
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry lists this organization as the lead sponsor: Oslo University Hospital (`cardio:org-oslo-university-hospital`)
- Registry lists this organization as a collaborator: Medtronic (`cardio:medtronic`)
- Registry lists this organization as a collaborator: ResMed (`cardio:org-resmed`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Effect of Continuous Positive Airway Pressure on Arrhythmia in Atrial Fibrillation and Sleep Apnea: A Randomized Controlled Trial (`cardio:pubmed-33938787`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: High levels of the adipokines leptin and metrnl in patients with paroxysmal atrial fibrillation and obstructive sleep apnea are not associated with the severity of sleep apnea or the burden of atrial fibrillation (`cardio:pubmed-41110405`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: f502aa1183f15931d96f13f71e5b6ae17014236765498d9f788f8998bc7a5be1
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
